TAG:
ehi
Privacy Officer Shares Lessons on ID Theft
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
CEO SUMMARY: “Nothing teaches like experience.” That adage aptly describes the lessons learned at a Seattle hospital after a case of patient identity theft surfaced. Laboratories and pathology groups must be just as alert to the potential for patient identity theft as they are to inap…
Labs in United Kingdom Pressured to Change
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
CEO SUMMARY: Across the United Kingdom, the physical lay-out, instrumentation, and operation of laboratories is very close to that of laboratories in the United States and Canada. The source of most differences is how the healthcare system in the United Kingdom funds clinical services and…
Profit Squeeze Pressures Specialty Laboratories
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Despite much success and milestones at Specialty Laboratories during the past 36 months, it has yet to achieve the most important goal of all: net profits. One reason is familiar to all laboratory administrators and pathologists: with its existing fixed overhead and cost stru…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
HPV Vaccine Developers Racing to Marketplace
By Robert Michel | From the Volume XI No. 16 – November 22, 2004 Issue
CEO SUMMARY: At least ten companies are working on an HPV vaccine that can prevent cervical cancer. The leading two companies have Phase III clinical trials under way and expect to earn regulatory approval within the next 24 to 30 months. The speedy arrival of an HPV vaccine in the market…
Medicare Changes Policy On New Med Procedures
By Robert Michel | From the Volume XI No. 16 – November 22, 2004 Issue
CEO SUMMARY: Faced with a literal tidal wave of new medical procedures, new therapeutic drugs, and new diagnostic tests, Medicare is crafting a unique strategy. As a new clinical option reaches the market, Medicare will reimburse—but only if the patient participates in a clinical study …
BC Labs’ LOINC Venture Now Carries Pharma Info
By Robert Michel | From the Volume XI No. 15 – November 1, 2004 Issue
CEO SUMMARY: In British Columbia, two commercial laboratory companies are intense competitors. Yet, beginning in 2002, they jointly offered a single Web browser-based system for lab test results reporting. LOINC was the tool which linked their individual lab data repositories to the PathN…
Is Nation’s Best Quality Laboratory in Arizona?
By Robert Michel | From the Volume XI No.13 – September 20, 2004 Issue
CEO SUMMARY: Without much fanfare or public attention, one lab is achieving recognition for quality and service excellence possibly unmatched in the clinical laboratory industry. In 2003, Sonora Quest Laboratories received Arizona’s Pioneer Award for Quality—the first healthcare provi…
ChromaVision Targets National AP Market
By Robert Michel | From the Volume XI No. 12 – August 30, 2004 Issue
CEO SUMMARY: Three new business strategies are moving ChromaVision into different segments of the laboratory testing marketplace. The company has built a new laboratory facility and will support local pathology groups with advanced diagnostic technology. It is also expanding its presence …
Mayo’s Scottsdale Hospital Lab Hits Big “Lean” Home Runs
By Robert Michel | From the Volume XI No. 12 – August 30, 2004 Issue
CEO SUMMARY: Are Lean and Six Sigma techniques ready to make a big contribution in the laboratories of smaller hospitals? If you ask lab managers at Mayo Clinic’s Scottsdale Hospital, the answer is an unqualified “Yes!” Their 15-week Lean project in the hospital’s high volume core…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized